However, the high expression of IL-32β was increased in cancer tissues and serum in patients with hepatocellular carcinoma, and the inhibition of IL-32α expression using siRNA resulted in decreased expression of the antiapoptotic protein bcl-2, inhibiting cell growth and apoptosis [59]. Here, BCL2 is linked to hepatocellular carcinoma.